Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate that no more participants are being sought. A new revision (v3.6.0) has been added, while the earlier revision (v3.5.5) has been removed.
    Difference
    0.2%
    Check dated 2026-06-12T16:36:53.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.5.5, and the previous revision v3.5.4 has been removed. This reflects an update to the page's versioning information within the study's history.
    Difference
    0.1%
    Check dated 2026-06-05T12:40:11.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The record history now shows the latest revision (v3.5.4) as the current version, replacing the earlier v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:26:46.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site or interface version change rather than any update to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:53.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:10.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the record history and Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.